ImmuPharma (LON:IMM) Stock Price Up 4.9% – Time to Buy?

by · The Markets Daily

ImmuPharma plc (LON:IMM – Get Free Report) was up 4.9% on Saturday . The stock traded as high as GBX 4.70 ($0.06) and last traded at GBX 3.67 ($0.04). Approximately 109,382,164 shares traded hands during trading, an increase of 245% from the average daily volume of 31,664,631 shares. The stock had previously closed at GBX 3.50 ($0.04).

ImmuPharma Stock Up 4.9 %

The stock has a market cap of £15.30 million, a P/E ratio of -367.30 and a beta of 1.53. The business’s 50-day simple moving average is GBX 1.40 and its two-hundred day simple moving average is GBX 1.65.

About ImmuPharma

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Read More